Does TELMISARTAN Cause Metastatic neoplasm? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Metastatic neoplasm have been filed in association with TELMISARTAN (telmisartan). This represents 0.2% of all adverse event reports for TELMISARTAN.
11
Reports of Metastatic neoplasm with TELMISARTAN
0.2%
of all TELMISARTAN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Metastatic neoplasm From TELMISARTAN?
Of the 11 reports, 10 (90.9%) required hospitalization.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which TELMISARTAN Alternatives Have Lower Metastatic neoplasm Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS